Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation
Angiology · 21.05.2026
DOI: 10.1177/00033197261453467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiology, online erschienen am 21.05.2026. Verfasst von Ibrahim Mortada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Continuous-flow left ventricular assist devices (CF-LVADs) are central to advanced heart failure management but are complicated by right ventricular failure (RVF) in up to 40% of patients, increasing morbidity and mortality and underscoring the need for robust prediction tools. We performed a single-center retrospective study of CF-LVAD recipients from March 2009 to May 2024. Of 326 patients, 205 met inclusion criteria; RVF was defined as need for inotropes or right ventricular assist device support. We compared established RVF risk scores (Michigan, Penn/Fitzpatrick, European Registry for Patients with Mechanical Circulatory Support [EUROMACS], Central venous pressure, severe Right ventricular dysfunction, preoperative Intubation, severe Tricuspid regurgitation, Tachycardia [CRITT]) using receiver operating characteristic analysis, logistic regression, and internal validation. Among 205 patients, 81 (39.5%) developed post-LVAD RVF. The EUROMACS score had the highest predictive value ( C -statistic 0.670, P < .001), followed by CRITT (0.653, P < .001), Penn (0.616, P = .004), and Michigan (0.606, P = .005). Youden-optimized cutoffs were derived to summarize sensitivity, specificity, positive predictive value, and negative predictive value. Mortality analysis was performed as a secondary exploratory endpoint. Overall, discrimination of existing RVF scores remained modest. EUROMACS performed best but highlighted the need to refine models with contemporary hemodynamic and echocardiographic metrics and to pursue rigorous external validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, USA.
- Division of Cardiology, Department of Medicine, University of Iowa, IA, USA.
ORCID-Profile: Ibrahim Mortada
Zitieren
APA
Mortada, I., Mhanna, M., Gollapally Krishna, S. R., Qadeer, A., Al-Abdouh, A., Ruiz Duque, E., Mansour, S., & Jneid, H. (2026). Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation. Angiology. https://doi.org/10.1177/00033197261453467
Vancouver
Mortada I, Mhanna M, Gollapally Krishna SR, Qadeer A, Al-Abdouh A, Ruiz Duque E, et al. Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation. Angiology. 2026. doi:10.1177/00033197261453467
BibTeX
@article{Mortada2026,
author = {Mortada, Ibrahim and Mhanna, Mohammed and Gollapally Krishna, Shiva Raju and Qadeer, Abdul and Al-Abdouh, Ahmad and Ruiz Duque, Ernesto and Mansour, Shareef and Jneid, Hani},
title = {Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation},
journal = {Angiology},
year = {2026},
doi = {10.1177/00033197261453467}
}
EUVIMED